{"entity":{"type":"insider","cik":"0001260651","url":"/insider/0001260651","json_url":"/insider/0001260651.json","name":"GARRETT J STEVEN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":13,"first":"2003-12-17","last":"2004-11-12","span_basis":"filed_date"},"name_variants":[{"name":"GARRETT J STEVEN","source":"filing","n_filings":13,"first_seen":"2003-12-17","last_seen":"2004-11-12"}],"transactions":[{"id":363752,"accession":"0001260651-04-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001260651-04-000016","line_url":"/filing/0001260651-04-000016#line-2","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":30.58,"price_display":"30.58","price_state":"stated","total_value":137610.0,"total_display":"137,610.00","total_whole":"137,610","shares_owned_after":3668.0,"shares_owned_after_display":"3,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-11","filed_date":"2004-11-12","scope":"insider"},{"id":655964,"accession":"0001260651-04-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001260651-04-000015","line_url":"/filing/0001260651-04-000015","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.39,"price_display":"30.39","price_state":"stated","total_value":151950.0,"total_display":"151,950.00","total_whole":"151,950","shares_owned_after":4868.0,"shares_owned_after_display":"4,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-10-11","filed_date":"2004-10-12","scope":"insider","n_lines":2},{"id":229063,"accession":"0001260651-04-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001260651-04-000014","line_url":"/filing/0001260651-04-000014#line-2","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-09-13","filed_date":"2004-09-14","scope":"insider"},{"id":335490,"accession":"0001260651-04-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001260651-04-000013","line_url":"/filing/0001260651-04-000013#line-2","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.53,"price_display":"30.53","price_state":"stated","total_value":152650.0,"total_display":"152,650.00","total_whole":"152,650","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-11","filed_date":"2004-08-11","scope":"insider"},{"id":214553,"accession":"0001260651-04-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001260651-04-000010","line_url":"/filing/0001260651-04-000010#line-2","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":31.955,"price_display":"31.96","price_state":"stated","total_value":159775.0,"total_display":"159,775.00","total_whole":"159,775","shares_owned_after":7100.0,"shares_owned_after_display":"7,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-07-12","filed_date":"2004-07-12","scope":"insider"},{"id":9280276,"accession":"0001260651-04-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001260651-04-000009","line_url":"/filing/0001260651-04-000009","is_derivative":false,"issuer_cik":"0001260651","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0001260651","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.77,"price_display":"32.77","price_state":"stated","total_value":163850.0,"total_display":"163,850.00","total_whole":"163,850","shares_owned_after":7100.0,"shares_owned_after_display":"7,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-16","filed_date":"2004-06-16","scope":"insider","n_lines":2},{"id":462184,"accession":"0001260651-04-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001260651-04-000008","line_url":"/filing/0001260651-04-000008","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Stock Option","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.77,"price_display":"32.77","price_state":"stated","total_value":163850.0,"total_display":"163,850.00","total_whole":"163,850","shares_owned_after":7100.0,"shares_owned_after_display":"7,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-16","filed_date":"2004-06-16","scope":"insider","n_lines":2},{"id":401833,"accession":"0001260651-04-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001260651-04-000007","line_url":"/filing/0001260651-04-000007#line-1","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":27.015,"price_display":"27.02","price_state":"stated","total_value":54030.0,"total_display":"54,030.00","total_whole":"54,030","shares_owned_after":10900.0,"shares_owned_after_display":"10,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-17","filed_date":"2004-05-17","scope":"insider"},{"id":273726,"accession":"0001260651-04-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001260651-04-000005","line_url":"/filing/0001260651-04-000005#line-2","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Sr VP Clincal Research)","role_mark":"O","role_mark_label":"Officer (Sr VP Clincal Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Clincal Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":29.26,"price_display":"29.26","price_state":"stated","total_value":58520.0,"total_display":"58,520.00","total_whole":"58,520","shares_owned_after":12900.0,"shares_owned_after_display":"12,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-04-16","filed_date":"2004-04-19","scope":"insider"},{"id":207776,"accession":"0001260651-04-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001260651-04-000003","line_url":"/filing/0001260651-04-000003#line-1","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Sr VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Sr VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":24.26,"price_display":"24.26","price_state":"stated","total_value":36390.0,"total_display":"36,390.00","total_whole":"36,390","shares_owned_after":12900.0,"shares_owned_after_display":"12,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-03-16","filed_date":"2004-03-17","scope":"insider"},{"id":580268,"accession":"0001260651-04-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001260651-04-000002","line_url":"/filing/0001260651-04-000002#line-1","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Sr VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Sr VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":26.9,"price_display":"26.90","price_state":"stated","total_value":53800.0,"total_display":"53,800.00","total_whole":"53,800","shares_owned_after":14400.0,"shares_owned_after_display":"14,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-02-17","filed_date":"2004-02-19","scope":"insider"},{"id":288189,"accession":"0001260651-04-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001260651-04-000001","line_url":"/filing/0001260651-04-000001#line-1","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Senior VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Senior VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP Clinical Research","security_title":"Common Stock, $.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.05,"price_display":"25.05","price_state":"stated","total_value":50100.0,"total_display":"50,100.00","total_whole":"50,100","shares_owned_after":16400.0,"shares_owned_after_display":"16,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-01-16","filed_date":"2004-01-20","scope":"insider"},{"id":123382,"accession":"0001260651-03-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001260651-03-000006","line_url":"/filing/0001260651-03-000006#line-1","is_derivative":false,"issuer_cik":"0000809875","issuer_name":"ATRIX LABORATORIES INC","issuer_ticker":"ATRX","issuer_name_source":null,"issuer_url":"/issuer/0000809875","owner_cik":"0001260651","owner_name":"GARRETT J STEVEN","owner_display_name":"GARRETT J STEVEN","owner_url":"/insider/0001260651","role":"Officer (Sr VP Clinical Research)","role_mark":"O","role_mark_label":"Officer (Sr VP Clinical Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Clinical Research","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":22.15,"price_display":"22.15","price_state":"stated","total_value":22150.0,"total_display":"22,150.00","total_whole":"22,150","shares_owned_after":19900.0,"shares_owned_after_display":"19,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-12-16","filed_date":"2003-12-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000809875","name":"ATRIX LABORATORIES INC","url":"/issuer/0000809875","role":"Officer (Senior VP Clinical Research)","n_filings":13,"first_seen":"2003-12-17","last_seen":"2004-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001260651","retrieved_at":"2026-08-24T02:52:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}